Compare BLCO & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | GTX |
|---|---|---|
| Founded | 1853 | 2018 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2022 | 2021 |
| Metric | BLCO | GTX |
|---|---|---|
| Price | $16.71 | $30.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $18.45 | ★ $20.40 |
| AVG Volume (30 Days) | 417.0K | ★ 2.1M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $5,101,000,000.00 | $3,584,000,000.00 |
| Revenue This Year | $8.65 | $4.16 |
| Revenue Next Year | $5.59 | $3.27 |
| P/E Ratio | ★ N/A | $63.57 |
| Revenue Growth | ★ 6.47 | 3.14 |
| 52 Week Low | $13.53 | $12.26 |
| 52 Week High | $18.92 | $36.25 |
| Indicator | BLCO | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 46.11 |
| Support Level | $16.74 | $30.49 |
| Resistance Level | $17.61 | $32.69 |
| Average True Range (ATR) | 0.54 | 1.20 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 76.45 | 55.30 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.